A new way to screen for risk of colorectal, gastric and pancreatic cancers will be available soon for use in the United States.
Riskguard (Exact Sciences), a multigene panel for hereditary cancer screening using blood or saliva samples, can identify 10 common types of cancer, which also includes breast, endometrial, endocrine, kidney, ovarian, prostate and skin cancers, according to the company.
In addition to helping evaluate a patient’s cancer risk, the assessment can be used to evaluate